Changyun H.
Adept Therapeutics Inc
- Role
- Member of the Board of Advisors at TREGSHIELD BIO Inc.
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Changyun H.
A seasoned antibody drug hunter and immunologist with extensive biomedical research…
Experience
Member of the Board of Advisors
Mar 2025 — Present
TregShield Bio is pioneering tissue-restricted activation of biologics to treat autoimmune and inflammatory diseases with unmatched precision. Our platform ensures activation occurs only within diseased organs — unlocking powerful immune modulation safely. Our lead program, TRS-001, is a first-in-class pancreas-activable biologic for type 1 diabetes, with a dual mechanism of action: neutralizing pathogenic T cells and boosting regulatory T cells (Tregs). Beyond T1D, the platform is designed to expand into multiple high-value immune indications.
Education
Fudan University
Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology
2003
Colorado State University
Trainee, Biology of Disease Vector
2005
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.